Al­ler­gan scores a PhI­II win with an ac­ne drug now head­ed to the FDA

Al­ler­gan is tee­ing up a new drug ap­pli­ca­tion for sare­cy­cline af­ter in­ves­ti­ga­tors re­port­ed that the ac­ne treat­ment scored promis­ing da­ta in two Phase III stud­ies …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER